Back to search

Article

Cell therapy could benefit from BCG: how anti-tumour BCG-primed NK cells selectively proliferate over other lymphocytes and efficiently kill cancer cells

2023-09-25

Abstract excerpt

<title>Abstract</title> <p>Natural killer (NK) cell-based immunotherapies are safe, promising treatments for patients with cancer. Nevertheless, the short-lived nature of NK cells, the heterogeneity of NK populations and the need to infuse large number of cells for efficient tumour elimination represent important challenges for the development of NK cell-based therapies. Therefore, improved approaches to produce...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bd9a7b6b-7b33-52bd-9872-bb7b4df1e03c
DOI
10.21203/rs.3.rs-3356129/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cell therapy could benefit from BCG: how anti-tumour BCG-primed NK cells selectively proliferate over other lymphocytes and efficiently kill cancer cellsDOI 10.21203/rs.3.rs-3356129/v1
Select a neighboring publication to make it the new centre.